STK33
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| serine/threonine kinase 33 | MIM:607670 | Ensembl:ENSG00000130413 | HGNC:HGNC:14568 | PA37900 | 11p15.4 |
GO terms in STK33
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IBA | GO:0042770 | signal transduction in response to DNA damage |
| BP | IBA | GO:0042981 | regulation of apoptotic process |
| BP | IBA | GO:0044773 | mitotic DNA damage checkpoint |
| BP | ISS | GO:0046777 | protein autophosphorylation |
| CC | IBA | GO:0005634 | nucleus |
| CC | IBA | GO:0005737 | cytoplasm |
| CC | IEA | GO:0048471 | perinuclear region of cytoplasm |
| MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
| MF | ISS | GO:0004674 | protein serine/threonine kinase activity |
| MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: STK33
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in STK33
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD748 | PHA-665752 | 1 |
| iGMDRD577 | BIX01294 | 4 |
| iGMDRD314 | Tanespimycin | 4 |
| iGMDRD188 | Piperlongumine | 2 |
| iGMDRD100 | Zebularine | 3 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD679 | Bistramide A | 4 |
| iGMDRD158 | NSC141540 | 2 |
| iGMDRD513 | BML-259 | 3 |
| iGMDRD309 | 17AAG | 2 |
| iGMDRD77 | Itraconazole | 3 |
| iGMDRD187 | BRD9876 | 2 |
| iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 4 |
| iGMDRD427 | ABT737 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in STK33
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.